Zepbound™ 2.5mg (tirzepatide) Injectable Pen

Product Overview

The Zepbound™ 2.5 mg single-dose pen is the foundational starting point for the therapeutic weight management regimen. Zepbound™ is a prescription-only injectable medication that acts as a dual agonist for both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. By mimicking these hormones, the 2.5 mg injection initiates the biological process of signaling satiety to the brain and slowing gastric emptying to help reduce caloric intake as part of a comprehensive weight management plan.

Key Features & Benefits

• Initiation Strength: The 2.5 mg dose is specifically designed as the induction strength to help your body safely acclimate to the medication’s mechanism of action.

• Dual-Action Receptor Agonism: Uniquely targets both GIP and GLP-1 receptors to provide comprehensive metabolic support.

• Pre-Filled Convenience: Delivered in a single-dose, easy-to-use injectable pen designed for seamless, once-weekly administration.

• Supports Sustained Weight Management: When combined with a reduced-calorie diet and increased physical activity, it facilitates meaningful and sustained weight loss.

Product Specifications

Administration Guidance

The 2.5 mg pen is intended for subcutaneous use once every seven days.

• Injection Sites: You may inject into the abdomen (at least 2 inches away from the navel), the thigh, or the upper arm.

• Consistency: Choose a specific day of the week for your injection and try to maintain that schedule consistently.

• Rotation: Rotate your injection site with each weekly dose to minimize potential site reactions.

Important Clinical Note: Zepbound™ is a prescription medication. The 2.5 mg dose is intended for initiation only and should be used under the direct supervision of a healthcare professional as part of a weight management program including diet and exercise.